Why Latest Breakthroughs in Treating Mesothelioma Cancer Return better Success rate?

Innovative Treatment Options for Mesothelioma Cancer

Mesothelioma cancer is a fatal form of lung cancer instigated by asbestos. The number and the death toll of the affected patients are relentlessly increasing for this lethal affliction, nonetheless researchers and doctors are ceaselessly striving to contain and cure this malignant condition. The available procedures of identification and treatment of mesothelioma cancer are being revolutionized as newer techniques are introduced for therapeutic management of the ailment.

Traditional Treatment Options

The conventional methods to alleviate the perils of mesothelioma cancer include surgical treatments like pleurectomy and pneumonectomy.  While pleurectomy entails the removal of the certain part of the affected tissue, pneumonectomy is a severe surgery involving the amputation of the entire distressed organ. Chemotherapy is another example of the widespread methods but this is excruciatingly painful for the patient. Even with the usage of intense drugs, the procedure has proven to have a meager success rate of 10-20%. Radiation and palliative therapies are a couple of other treatment options available in this regard.

Latest Breakthroughs in Treating Mesothelioma Cancer

Pioneering procedural changes in the treatment take place owing to the usefulness and competence of the applied clinical trials. The most recent breakthrough is related to the drug named Aldara.

In the year end of 2008, the scientists working at the Nation Centre for Asbestos Related Diseases at Sir Charles Gairdner hospital, Australia revealed that a commercial cream (currently used for treatment of skin cancer) when injected with anti-CD40 (a stimulant) into mice with mesothelioma cancer, showed 50% success. This eminent progress reveals that the injection induces the production of ‘killers’ (specialized cells), which track and end the malignant cells exclusively. Extensive work is being done on this discovery as it has a greater potency of being the first effective cure for mesothelioma cancer.

Other new treatment options comprise the recently developed chemotherapy drug named Alimta, which depicted a success rate of 20-35% when tested at the clinic with a combination of other chemo drugs. Other treatments include Brach therapy, which is a sophisticated radiotherapy executed by embedding small radioactive components neighboring to or within the malignant tumors of mesothelioma cancer. The radioactive materials tend to eradicate the cancerous cells. It has testified to be relatively quick, painless and easily manageable.

Gene therapy is yet another curative option that holds a significant position in handling mesothelioma cancer. In this case, we assume to target and rectify the anomalous DNA level problems and then counterbalance it for the irregular genes removed/replaced. The Photodynamic therapy (PDT) is also known to have much potential in the treatment of the disease as it’s is based on the principle of destruction of certain cells containing photosensitive drugs through the exposure to light of a particular frequency. Doctors are working further in this regard to transmit photosensitive chemicals to cancerous tumors, while keeping the good cells intact. Although, this procedure has some moderate side-effects, they’re in course of being minimized through further research.

Immunotherapy is also contemplated to be an efficient method through which biologically immune system is triggered to identify and eliminate the abnormal cells. In this procedure, biological response modifiers (BRMs) modify the cells of the immune system that are the root cause of mesothelioma cancer thereby paving way to their natural destruction.